Search results
Charles River and Sanofi collab to replace animals with virtual controls in preclinical research
FierceBiotech· 15 hours agoCharles River Laboratories and Sanofi are working on a new project in which virtual control animals...
Data needed to forge the link between AI and mRNA
Pharmaceutical Technology via Yahoo Finance· 2 hours agoAgainst this backdrop, several deals are pushing forth investments in both mRNA and AI. In 2021, Sanofi acquired the mRNA tech company Translate Bio,...
My Novavax stock price forecast was correct: what next now? | Invezz
Invezz· 9 hours agoNovavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 6 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Delaware judge lets more than 70,000 Zantac lawsuits go forward By Reuters
Investing.com· 3 days agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
Zacks via Yahoo Finance· 2 days agoDenali's (DNLI) DNL126, an investigational enzyme replacement therapy, gets selected for the START...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via AOL· 6 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 6 days agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
Will Zantac ruling make Delaware a mass torts magnet?
Reuters· 3 days agoIf you are mass torts lawyer, you should be paying attention to a trend that has emerged in...
Sanofi’s Chronic Lung Disease Drug Gets EU Regulator Backing
Bloomberg· 6 days agoSanofi’s Dupixent is close to being approved in Europe for use in helping patients with a chronic...
